FIELD: medicine, cardiology, therapy, biochemistry. SUBSTANCE: method involves treatment of serum blood with 7% solution of polyethylene glycol-6000 and serum blood precipitate prepared after treatment with polyethylene glycol-600 is incubated with dye sudan B at temperature 40 C into dark thermostat for 1 h and precipitated is added into agarose gel well increased by 2-fold by volume for electrophoretic analysis including additional determination of LP(a) fraction. EFFECT: enhanced precision of assay. 8 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING EFFICIENCY IN TREATING ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210077C2 |
METHOD FOR PREDICTING THE FLOW OF ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210076C2 |
METHOD FOR EVALUATING EFFICIENCY IN TREATING ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210075C2 |
METHOD FOR PREDICTING THE FLOW OF ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2210078C2 |
METHOD FOR ESTIMATING CLINICAL EFFECTIVENESS OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2462722C1 |
METHOD OF ESTIMATING CLINICAL EFFECTIVENESS IN CHRONIC HEART DISEASE | 2009 |
|
RU2396567C1 |
METHOD OF FRACTION TEST OF MODIFIED BLOOD LIPOPROTEINS | 2010 |
|
RU2428698C1 |
METHOD OF ESTIMATING EFFICIENCY OF ISCHEMIC HEART DISEASE TREATMENT | 2010 |
|
RU2439581C1 |
METHOD OF DETERMINATION OF BLOOD LIPOPROTEID FRACTIONS IN PATIENTS WITH HEART ISCHEMIC DISEASE | 2000 |
|
RU2200950C2 |
METHOD OF DETERMINING FRACTIONS OF MODIFIED LIPOPROTEINS IN BLOOD | 2009 |
|
RU2413952C2 |
Authors
Dates
2003-08-10—Published
2000-09-01—Filed